• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型肽修饰溶菌酶对鲍曼不动杆菌和铜绿假单胞菌的抗菌活性

Antibacterial Activity of a Novel Peptide-Modified Lysin Against Acinetobacter baumannii and Pseudomonas aeruginosa.

作者信息

Yang Hang, Wang Mengyue, Yu Junping, Wei Hongping

机构信息

Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences Wuhan, China.

出版信息

Front Microbiol. 2015 Dec 22;6:1471. doi: 10.3389/fmicb.2015.01471. eCollection 2015.

DOI:10.3389/fmicb.2015.01471
PMID:26733995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4686776/
Abstract

The global emergence of multidrug-resistant (MDR) bacteria is a growing threat to public health worldwide. Natural bacteriophage lysins are promising alternatives in the treatment of infections caused by Gram-positive pathogens, but not Gram-negative ones, like Acinetobacter baumannii and Pseudomonas aeruginosa, due to the barriers posed by their outer membranes. Recently, modifying a natural lysin with an antimicrobial peptide was found able to break the barriers, and to kill Gram-negative pathogens. Herein, a new peptide-modified lysin (PlyA) was constructed by fusing the cecropin A peptide residues 1-8 (KWKLFKKI) with the OBPgp279 lysin and its antibacterial activity was studied. PlyA showed good and broad antibacterial activities against logarithmic phase A. baumannii and P. aeruginosa, but much reduced activities against the cells in stationary phase. Addition of outer membrane permeabilizers (EDTA and citric acid) could enhance the antibacterial activity of PlyA against stationary phase cells. Finally, no antibacterial activity of PlyA could be observed in some bio-matrices, such as culture media, milk, and sera. In conclusion, we reported here a novel peptide-modified lysin with significant antibacterial activity against both logarithmic (without OMPs) and stationary phase (with OMPs) A. baumannii and P. aeruginosa cells in buffer, but further optimization is needed to achieve broad activity in diverse bio-matrices.

摘要

多重耐药(MDR)细菌在全球范围内的出现对全球公共卫生构成了日益严重的威胁。天然噬菌体溶菌酶是治疗革兰氏阳性病原体引起的感染的有前景的替代物,但对于革兰氏阴性病原体,如鲍曼不动杆菌和铜绿假单胞菌则无效,因为它们的外膜会造成障碍。最近,发现用抗菌肽修饰天然溶菌酶能够突破这些障碍,并杀死革兰氏阴性病原体。在此,通过将天蚕素A肽的第1 - 8位残基(KWKLFKKI)与OBPgp279溶菌酶融合构建了一种新的肽修饰溶菌酶(PlyA),并研究了其抗菌活性。PlyA对对数生长期的鲍曼不动杆菌和铜绿假单胞菌显示出良好且广泛的抗菌活性,但对稳定期细胞的活性则大大降低。添加外膜通透剂(EDTA和柠檬酸)可以增强PlyA对稳定期细胞的抗菌活性。最后,在一些生物基质中,如培养基、牛奶和血清中未观察到PlyA的抗菌活性。总之,我们在此报道了一种新型的肽修饰溶菌酶,其在缓冲液中对对数期(无外膜蛋白)和稳定期(有外膜蛋白)的鲍曼不动杆菌和铜绿假单胞菌细胞均具有显著的抗菌活性,但需要进一步优化以在多种生物基质中实现广泛的活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e2/4686776/b4ad839dc25b/fmicb-06-01471-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e2/4686776/30d6d4e2db82/fmicb-06-01471-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e2/4686776/2770e2e86848/fmicb-06-01471-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e2/4686776/702fe4e981c0/fmicb-06-01471-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e2/4686776/81eb1bd57cb9/fmicb-06-01471-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e2/4686776/b4ad839dc25b/fmicb-06-01471-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e2/4686776/30d6d4e2db82/fmicb-06-01471-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e2/4686776/2770e2e86848/fmicb-06-01471-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e2/4686776/702fe4e981c0/fmicb-06-01471-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e2/4686776/81eb1bd57cb9/fmicb-06-01471-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e2/4686776/b4ad839dc25b/fmicb-06-01471-g005.jpg

相似文献

1
Antibacterial Activity of a Novel Peptide-Modified Lysin Against Acinetobacter baumannii and Pseudomonas aeruginosa.一种新型肽修饰溶菌酶对鲍曼不动杆菌和铜绿假单胞菌的抗菌活性
Front Microbiol. 2015 Dec 22;6:1471. doi: 10.3389/fmicb.2015.01471. eCollection 2015.
2
Engineering a Lysin with Intrinsic Antibacterial Activity (LysMK34) by Cecropin A Fusion Enhances Its Antibacterial Properties against Acinetobacter baumannii.通过融合抗菌肽 Cecropin A 工程化具有内在抗菌活性的溶菌酶 (LysMK34) 增强其对鲍曼不动杆菌的抗菌特性。
Appl Environ Microbiol. 2022 Jan 11;88(1):e0151521. doi: 10.1128/AEM.01515-21. Epub 2021 Oct 20.
3
Membrane-Permeable Antibacterial Enzyme against Multidrug-Resistant .细胞膜通透型抗多重耐药抗菌酶
ACS Infect Dis. 2021 Aug 13;7(8):2192-2204. doi: 10.1021/acsinfecdis.1c00222. Epub 2021 Jul 7.
4
Engineering of lysin by fusion of antimicrobial peptide (cecropin A) enhances its antibacterial properties against multidrug-resistant .通过融合抗菌肽(天蚕素A)对溶菌酶进行工程改造,可增强其对多重耐药菌的抗菌特性。
Front Microbiol. 2022 Sep 26;13:988522. doi: 10.3389/fmicb.2022.988522. eCollection 2022.
5
Intrinsic Antimicrobial Peptide Facilitates a New Broad-Spectrum Lysin LysP53 to Kill In Vitro and in a Mouse Burn Infection Model.内在抗菌肽促进新型广谱溶菌酶 LysP53 体外杀伤和小鼠烧伤感染模型。
ACS Infect Dis. 2021 Dec 10;7(12):3336-3344. doi: 10.1021/acsinfecdis.1c00497. Epub 2021 Nov 17.
6
Novel Phage Lysin Abp013 against .新型抗……的噬菌体裂解酶Abp013
Antibiotics (Basel). 2022 Jan 28;11(2):169. doi: 10.3390/antibiotics11020169.
7
The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region.通过将解淀粉芽孢杆菌噬菌体溶菌酶结合结构域D8融合到C末端区域,增强了大肠杆菌噬菌体溶菌酶lysep3的抗菌活性。
J Microbiol. 2017 May;55(5):403-408. doi: 10.1007/s12275-017-6431-6. Epub 2017 Jan 26.
8
PaP1, a Broad-Spectrum Lysin-Derived Cationic Peptide to Treat Polymicrobial Skin Infections.PaP1,一种用于治疗多种微生物引起的皮肤感染的广谱溶菌酶衍生阳离子肽。
Front Microbiol. 2022 Mar 10;13:817228. doi: 10.3389/fmicb.2022.817228. eCollection 2022.
9
Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa.新型噬菌体溶菌酶 LysSS 对鲍曼不动杆菌和铜绿假单胞菌的抗菌活性。
J Glob Antimicrob Resist. 2020 Sep;22:32-39. doi: 10.1016/j.jgar.2020.01.005. Epub 2020 Jan 30.
10
A Novel Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes.一种新型溶菌酶 LysAB54,对多种革兰氏阴性菌具有高效抗菌活性。
Front Cell Infect Microbiol. 2021 Mar 2;11:637313. doi: 10.3389/fcimb.2021.637313. eCollection 2021.

引用本文的文献

1
Expanding structural insights into DNA packaging apparatus and endolysin LysSA05 function of Epsilon15 bacteriophage.拓展对Epsilon15噬菌体DNA包装装置和内溶素LysSA05功能的结构认识。
Front Cell Infect Microbiol. 2025 Aug 14;15:1643576. doi: 10.3389/fcimb.2025.1643576. eCollection 2025.
2
Phage and Endolysin Therapy Against Antibiotics Resistant Bacteria: From Bench to Bedside.噬菌体和溶菌酶治疗耐药细菌:从实验室到临床应用
MedComm (2020). 2025 Jul 13;6(7):e70280. doi: 10.1002/mco2.70280. eCollection 2025 Jul.
3
Endolysins and membrane-active peptides: innovative engineering strategies against gram-negative bacteria.

本文引用的文献

1
Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology.铜绿假单胞菌和鲍曼不动杆菌中新兴的广谱耐药性:机制与流行病学。
Int J Antimicrob Agents. 2015 Jun;45(6):568-85. doi: 10.1016/j.ijantimicag.2015.03.001. Epub 2015 Mar 24.
2
Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria.突破障碍:扩大溶菌酶作为新型抗革兰氏阴性菌抗菌剂的应用
Future Microbiol. 2015;10(3):377-90. doi: 10.2217/fmb.15.8.
3
The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.
内溶素和膜活性肽:针对革兰氏阴性菌的创新工程策略。
Front Microbiol. 2025 Jun 3;16:1603380. doi: 10.3389/fmicb.2025.1603380. eCollection 2025.
4
Endolysins as Effective Agents for Decontaminating , , and on Mung Bean Seeds.内溶素作为绿豆种子去污、[此处原文缺失部分内容]和[此处原文缺失部分内容]的有效试剂。
Int J Mol Sci. 2025 Feb 26;26(5):2047. doi: 10.3390/ijms26052047.
5
Development of Chimera AMP-Endolysin with Wider Spectra Against Gram-Negative Bacteria Using High-Throughput Assay.利用高通量检测技术开发对革兰氏阴性菌具有更广泛谱的嵌合AMP-内溶素
Viruses. 2025 Jan 30;17(2):200. doi: 10.3390/v17020200.
6
Natural peptides and their synthetic congeners acting against through the membrane and cell wall: latest progress.作用于细胞膜和细胞壁的天然肽及其合成类似物:最新进展。
RSC Med Chem. 2024 Nov 20;16(2):561-604. doi: 10.1039/d4md00745j. eCollection 2025 Feb 19.
7
Endolysins: a new antimicrobial agent against antimicrobial resistance. Strategies and opportunities in overcoming the challenges of endolysins against Gram-negative bacteria.内溶素:一种对抗抗菌素耐药性的新型抗菌剂。克服内溶素对革兰氏阴性菌挑战的策略与机遇。
Front Pharmacol. 2024 May 20;15:1385261. doi: 10.3389/fphar.2024.1385261. eCollection 2024.
8
Decoding the Structure-Function Relationship of the Muramidase Domain in E. coli O157.H7 Bacteriophage Endolysin: A Potential Building Block for Chimeric Enzybiotics.解析大肠杆菌 O157.H7 噬菌体溶菌酶的 Muramidase 结构与功能的关系:嵌合酶制剂的潜在构建模块。
Protein J. 2024 Jun;43(3):522-543. doi: 10.1007/s10930-024-10195-z. Epub 2024 Apr 25.
9
Engineering strategies and challenges of endolysin as an antibacterial agent against Gram-negative bacteria.作为一种抗革兰氏阴性菌的抗菌剂,溶菌素的工程策略和挑战。
Microb Biotechnol. 2024 Apr;17(4):e14465. doi: 10.1111/1751-7915.14465.
10
An Exploratory Review of the Potential of Lytic Proteins and Bacteriophages for the Treatment of Tuberculosis.溶菌蛋白和噬菌体治疗结核病潜力的探索性综述
Microorganisms. 2024 Mar 12;12(3):570. doi: 10.3390/microorganisms12030570.
革兰氏阴性菌中由外排介导的抗生素耐药性挑战。
Clin Microbiol Rev. 2015 Apr;28(2):337-418. doi: 10.1128/CMR.00117-14.
4
Molecular dissection of phage lysin PlySs2: integrity of the catalytic and cell wall binding domains is essential for its broad lytic activity.噬菌体裂解素PlySs2的分子剖析:催化结构域和细胞壁结合结构域的完整性对其广泛的裂解活性至关重要。
Virol Sin. 2015 Feb;30(1):45-51. doi: 10.1007/s12250-014-3535-6. Epub 2015 Feb 4.
5
Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model.新型噬菌体裂解酶能够在小鼠菌血症模型中杀死多重耐药革兰氏阴性菌鲍曼不动杆菌。
Antimicrob Agents Chemother. 2015 Apr;59(4):1983-91. doi: 10.1128/AAC.04641-14. Epub 2015 Jan 20.
6
Engineered bacteriophage lysins as novel anti-infectives.工程噬菌体溶菌酶作为新型抗感染药物。
Front Microbiol. 2014 Oct 16;5:542. doi: 10.3389/fmicb.2014.00542. eCollection 2014.
7
A thermostable Salmonella phage endolysin, Lys68, with broad bactericidal properties against gram-negative pathogens in presence of weak acids.一种热稳定的沙门氏菌噬菌体溶菌酶Lys68,在弱酸存在下对革兰氏阴性病原体具有广泛的杀菌特性。
PLoS One. 2014 Oct 7;9(10):e108376. doi: 10.1371/journal.pone.0108376. eCollection 2014.
8
Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogens.基于工程化内溶素的“溶菌酶制剂”用于对抗多重耐药革兰氏阴性病原体。
mBio. 2014 Jul 1;5(4):e01379-14. doi: 10.1128/mBio.01379-14.
9
Antibiotic-resistant Pseudomonas aeruginosa: focus on care in patients receiving assisted ventilation.耐抗生素铜绿假单胞菌:关注接受辅助通气患者的护理。
Future Microbiol. 2014;9(4):465-74. doi: 10.2217/fmb.14.7.
10
Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa.Art-175是一种对铜绿假单胞菌的多重耐药菌株和持留菌具有高效抗菌活性的物质。
Antimicrob Agents Chemother. 2014 Jul;58(7):3774-84. doi: 10.1128/AAC.02668-14. Epub 2014 Apr 21.